Product Information
NORTRIPTYLINE HCL 75 MG CAP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2573 per EA under NDC 00093081301. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Mar 27, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093081301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
NORTRIPTYLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074132FDA Approved
3/27/1995
TE Code
AB
On Market Since
4/5/1995
Pharmacological Classes
Price Statistics
The NADAC for NORTRIPTYLINE HCL 75 MG CAP has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 27.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2573 per EA |
|---|---|
| All-time high | $0.3188 (Nov 12, 2025) |
| All-time low | $0.1260 (May 22, 2024) |
| 52-week high | $0.3188 |
| 52-week low | $0.2500 |
| Median price | $0.1997 |
| Average price | $0.2025 |
| Largest weekly change | +29.0% (Aug 23, 2017) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NORTRIPTYLINE HCL 75 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for NORTRIPTYLINE HCL 75 MG CAP, manufactured by Teva Pharmaceuticals USA Inc., is $0.2573 per EA (NDC 00093081301), effective Aug 19, 2026.
How has the price of NORTRIPTYLINE HCL 75 MG CAP changed over time?
Over the history we have for it, the NADAC for NORTRIPTYLINE HCL 75 MG CAP has risen 27.2%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NORTRIPTYLINE HCL 75 MG CAP?
Since Nov 28, 2013, the NADAC for NORTRIPTYLINE HCL 75 MG CAP has ranged from a low of $0.1260 (May 22, 2024) to a high of $0.3188 (Nov 12, 2025), with a median of $0.1997 per EA.
Are there cheaper alternatives to NORTRIPTYLINE HCL 75 MG CAP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NORTRIPTYLINE HCL 75 MG CAP, is $0.2550 per EA — about 1% below NORTRIPTYLINE HCL 75 MG CAP.
Who manufactures NORTRIPTYLINE HCL 75 MG CAP?
NORTRIPTYLINE HCL 75 MG CAP (NDC 00093081301) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.